General Information of the Compound
Compound ID
CP0551410
Compound Name
N-[2-oxo-1-[[3-(propan-2-ylcarbamoylamino)phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]benzamide
    Show/Hide
Structure
Formula
C28H30N4O3
Molecular Weight
470.573
Canonical SMILES
CC(C)NC(=O)Nc1cccc(CN2c3ccccc3CCC(NC(=O)c3ccccc3)C2=O)c1
    Show/Hide
InChI
InChI=1S/C28H30N4O3/c1-19(2)29-28(35)30-23-13-8-9-20(17-23)18-32-25-14-7-6-10-21(25)15-16-24(27(32)34)31-26(33)22-11-4-3-5-12-22/h3-14,17,19,24H,15-16,18H2,1-2H3,(H,31,33)(H2,29,30,35)
    Show/Hide
InChIKey
OBWVKNHXJZRSTK-UHFFFAOYSA-N
Physicochemical Property
logP
4.4945
Rotatable Bonds
6
Heavy Atom Count
35
Polar Areas
90.54
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
3
Complexity
35

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44322256
ChEMBL ID
CHEMBL87139
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000074 SK-N-MC Homo sapiens (Human)  1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS